DUBLIN–(BUSINESS WIRE)–The “HPV Testing and Pap Test Market by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), PAP Test), End User (Laboratories, Hospitals, Physician’s Offices & Clinics), Region – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The global HPV testing and Pap test market is projected to reach USD 9.2 billion by 2027 from USD 4.9 billion in 2022, at a CAGR of 13.2% during the forecast period.
The HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market, by test type, during the forecast period
The HPV testing and Pap test market is segmented into HPV testing and Pap test. In 2021, HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market. Increase in number of product approval and increased focus on reducing cancer cases are major factor contributing to the growth of this segment.
The cervical cancer screening segment accounted for the highest growth rate in the HPV testing and Pap test market, by application, during the forecast period
The HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. In 2021, HPV testing segment accounted for the highest growth rate in the HPV testing and Pap test market. Increasing funding for the prevention of cervical cancer are major factor contributing to the growth of this segment.
The hospitals segment accounted for the highest growth rate in the HPV testing and Pap test market, by end user, during the forecast period
The HPV testing and Pap test market is segmented into laboratories, hospitals and physician’s offices & clinics based on end user. In 2021, the hospitals segment accounted for the highest growth rate in the HPV testing and Pap test market. Emerging markets offer lucrative growth opportunities are major factors contributing to the growth of this segment.
Asia Pacific: The fastest-growing region in HPV testing and Pap test market
The global HPV testing and Pap test market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of cervical cancer is driving the growth of the HPV testing and Pap test market in this region.
Market Dynamics
Drivers
Rising HPV Cases and Subsequent Increase in Cervical Cancer
Growing Awareness of Cervical Cancer Screening Programs
Increasing R&D Funding Initiatives on Cervical Cancer Prevention
Restraints
Growing Awareness of HPV Vaccination
Opportunities
Regulatory Guidelines for Cervical Cancer Screening
Innovative Improvements in HPV Tests
Introduction of HPV Primary Screening Tests
Technological Improvements in HPV Tests
Challenges
Uncertain Reimbursement Scenario
Stringent Regulatory & Legal Requirements
Operational Barriers
Companies Mentioned
Abbott Laboratories
Arbor Vita Corporation
Becton, Dickinson and Company
Dalrada Corporation
Everlywell Inc.
Femasys, Inc.
Hologic, Inc.
Jiangsu Mole Bioscience Co. Ltd.
Mylab Discovery Solutions Pvt. Ltd.
Neodiagnostix
Nurx Inc.
Qiagen N.V.
Quest Diagnostics
Roche Diagnostics
Sansure Biotech Inc.
Seegene, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/j1j7uv
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
